Patients are speaking up about how Bob Hugin’s decision to double the price of a lifesaving cancer drug resulted in debt, bankruptcy, and financial pain for middle class families. Patients from New Jersey and across America are warning Garden State voters that Big Pharma CEO Bob Hugin made more than $100 million by raising drug prices so high that cancer patients were forced into debt just to stay alive. Patients For Affordable Drugs NOW is publishing the stories as part of an effort to lift up the patient voice ahead of New Jersey’s U.S. Senate race and shine a light on Bob Hugin’s unscrupulous record.
“Bob Hugin’s unethical behavior to block less expensive generics and double the price of cancer medications patients need to stay alive has real-world consequences best expressed by those who have been hurt,” said David Mitchell, a cancer patient who took Hugin’s drug and president of Patients For Affordable Drugs NOW. “While he walked away with $140 million, people like Gulay Turan had to sell her furniture to afford the drug she needed to extend her mother’s life. Hugin cannot be a U.S. Senator.”
Read what patients have to say about their struggles to afford the prescription drugs Hugin price gouged.
For interviews with patients featured on the blog, contact Communications Director Juliana Keeping.
By Gulay Turan
East Rutherford, NJ
Gulay Turan maxed out credit cards and sold her furniture in order to afford her 66-year-old mother’s blood cancer medication, Revlimid. “I learned he increased the cost of my mother’s medicine by 100 percent in a decade, and I want him to know this action has consequences. The consequence is my mother is getting sicker, faster…If I could speak to the man responsible for the cost of my mother’s cancer medication, I would tell him about the heartbreak and crushing stress I feel.”
By Nancy Cartwright
Las Vegas, NV
To pay for the cancer drugs that kept her husband alive, Nancy Cartwright emptied her 401k, burned through her family’s savings account, and sold her family home. It wasn’t enough. Nancy and her husband eventually filed for bankruptcy. One of the drugs that forced the Cartwrights into financial ruin was the Celgene drug Thalomid.
“Besides bearing witness to my husband’s physical pain, I also witnessed the immense mental toll the cost of his medication took on him. It’s so hard to watch someone suffer and not be able to do anything to help. My hair even began to thin from stressing over his medication costs,” Cartwright said.
By Jackie Trapp
Jackie Trapp, 53, who has multiple myeloma, must pay for Revlimid or a similar drug for the rest of her life. She worries she will bankrupt her husband of 30 years due to her medication costs. “With my current insurance, I am facing as much as $19,167 per year just to stay alive,” she said, adding “There is no justification for Celgene’s price hikes under Bob Hugin and no justification for lack of transparency into his former corporation’s price hikes. Bob Hugin is a dangerous choice for senator.
Paid for by Patients For Affordable Drugs NOW, www.fightpharma.org. Not authorized by any candidate or candidate’s committee.